207 related articles for article (PubMed ID: 9225231)
1. Serum triglycerides and blood coagulation factors VII and X, and plasminogen activator inhibitor-1.
Ohni M; Mishima K; Nakajima K; Yamamoto M; Hata Y
J Atheroscler Thromb; 1995; 2 Suppl 1():S41-6. PubMed ID: 9225231
[TBL] [Abstract][Full Text] [Related]
2. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.
Tomura S; Nakamura Y; Doi M; Ando R; Ida T; Chida Y; Ootsuka S; Shinoda T; Yanagi H; Tsuchiya S; Marumo F
Am J Kidney Dis; 1996 Jun; 27(6):848-54. PubMed ID: 8651250
[TBL] [Abstract][Full Text] [Related]
4. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
[TBL] [Abstract][Full Text] [Related]
5. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
Lindgren A; Lindoff C; Norrving B; Astedt B; Johansson BB
Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
[TBL] [Abstract][Full Text] [Related]
6. Postprandial triglycerides and blood coagulation.
Silveira A
Exp Clin Endocrinol Diabetes; 2001; 109(4):S527-32. PubMed ID: 11453040
[TBL] [Abstract][Full Text] [Related]
7. Relation of habitual diet and cardiorespiratory fitness to blood coagulation and fibrinolytic factors.
Rankinen T; Rauramaa R; Väisänen S; Penttilä IM; Uusitupa M
Thromb Haemost; 1994 Feb; 71(2):180-3. PubMed ID: 8191395
[TBL] [Abstract][Full Text] [Related]
8. The variability of and associations between measures of blood coagulation, fibrinolysis and blood lipids.
Marckmann P; Sandström B; Jespersen J
Atherosclerosis; 1992 Oct; 96(2-3):235-44. PubMed ID: 1466654
[TBL] [Abstract][Full Text] [Related]
9. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
[TBL] [Abstract][Full Text] [Related]
10. Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1.
Aso Y; Matsumoto S; Fujiwara Y; Tayama K; Inukai T; Takemura Y
Metabolism; 2002 Apr; 51(4):471-6. PubMed ID: 11912556
[TBL] [Abstract][Full Text] [Related]
11. Blood coagulation and fibrinolysis in patients with acromegaly: increased plasminogen activator inhibitor-1 (PAI-1), decreased tissue factor pathway inhibitor (TFPI), and an inverse correlation between growth hormone and TFPI.
Erem C; Nuhoglu I; Kocak M; Yilmaz M; Sipahi ST; Ucuncu O; Ersoz HO
Endocrine; 2008 Jun; 33(3):270-6. PubMed ID: 19016004
[TBL] [Abstract][Full Text] [Related]
12. Hypertriglyceridemia, but not hypercholesterolemia, is associated with the alterations of fibrinolytic system.
Hiraga T; Shimada M; Tsukada T; Murase T
Horm Metab Res; 1996 Nov; 28(11):603-6. PubMed ID: 8960902
[TBL] [Abstract][Full Text] [Related]
13. Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus.
Ludwig S; Dharmalingam S; Erickson-Nesmith S; Ren S; Zhu F; Ma GM; Zhao R; Fenton JW; Ofosu FA; Velthuis HT; van Mierlo G; Shen GX
Diabetes Res Clin Pract; 2005 Nov; 70(2):110-8. PubMed ID: 16188573
[TBL] [Abstract][Full Text] [Related]
14. Blood coagulation and fibrinolysis in patients with hyperthyroidism.
Erem C; Ersoz HO; Karti SS; Ukinç K; Hacihasanoglu A; Değer O; Telatar M
J Endocrinol Invest; 2002 Apr; 25(4):345-50. PubMed ID: 12030606
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolysis in hypertriglyceridaemic subjects in response to venous occlusion.
Avellone G; Di Garbo V; Cordova R; Raneli G; De Simone R; Bompiani GD
Blood Coagul Fibrinolysis; 1993 Jun; 4(3):429-33. PubMed ID: 8329569
[TBL] [Abstract][Full Text] [Related]
16. High intakes of trans monounsaturated fatty acids taken for 2 weeks do not influence procoagulant and fibrinolytic risk markers for CHD in young healthy men.
Sanders TA; Oakley FR; Crook D; Cooper JA; Miller GJ
Br J Nutr; 2003 Jun; 89(6):767-76. PubMed ID: 12828793
[TBL] [Abstract][Full Text] [Related]
17. [Plasma haemostatic and fibrinolytic activities and their relationship to levels of serum lipids and apolipoproteins in endogenous hypertriglyceridemic patients].
Shen T; Bai H; Liu B; Liu Y; Zhang Z; Deng Z
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):405-8. PubMed ID: 12910674
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease.
Ossei-Gerning N; Wilson IJ; Grant PJ
Thromb Haemost; 1998 Apr; 79(4):736-40. PubMed ID: 9569183
[TBL] [Abstract][Full Text] [Related]
19. The relationships between insulin and plasminogen activator inhibitor 1 levels: assessment in groups of subjects with dyslipidaemia and hypertension.
Akanji AO; Al-Shayji I
Clin Chim Acta; 1998 Jun; 274(1):41-52. PubMed ID: 9681596
[TBL] [Abstract][Full Text] [Related]
20. Relationship between triglycerides and factor VIIc and plasminogen activator inhibitor type-1: lack of threshold value.
Chadarevian R; Bruckert E; Dejager S; Presberg P; Turpin G
Thromb Res; 1999 Nov; 96(3):175-82. PubMed ID: 10588459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]